Polymorphisms in the insulin response element of APOC-III gene promoter influence the correlation between insulin and triglycerides or triglyceride-rich lipoproteins in humans

International Journal of Obesity

Volumn 25, Issue 7, 2001, Pages 1012-1017

  Dallongeville, J ^a   Meirhaeghe, A ^a   Cottel, D ^a   Fruchart, J C ^a   Amouyel, P ^a   Helbecque, N ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

Author keywords

APOC III; Insulin; Lipoproteins; Triglycerides

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; GENE PRODUCT; INSULIN; LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESPONSE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROMOTER REGION; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; ALLELES; APOLIPOPROTEIN C-III; APOLIPOPROTEINS; APOLIPOPROTEINS C; FEMALE; FRANCE; HUMANS; INSULIN; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; QUESTIONNAIRES; SEX FACTORS; TRIGLYCERIDES;

EID: 0034968906     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0801658     Document Type: Article

References (35)

1. Hyperinsulinaemia and hypertriglyceridaemia
2. VLDL production is decreased to a similar extent by acute portal vs. peripheral venous insulin
3. Hyperinsulinemia and in vivo very-low-density lipoprotein-triglyceride kinetics
4. Free fatty acids, insulin resistance and lipoprotein metabolism
5. Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis
6. Overexpression of human lipoprotein lipase protects diabetic transgenic mice from diabetic hypertriglyceridemia and hypercholesterolemia
7. Transcriptional regulation of the apoC-III gene by insulin in diabetic mice: Correlation with changes in plasma triglyceride levels
8. Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia
9. Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III
10. Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles
11. Targeted disruption of the apolipoprotein C-III gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia
12. An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3′ untranslated region polymorphisms
13. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents
14. The role of a triplet repeat sequence of the very low density lipoprotein receptor gene in plasma lipid and lipoprotein level variability in humans
15. A simple salting out procedure for extracting DNA from human nucleated cells
16. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia
17. Gender related association between genetic variations of APOC-III gene and lipid and lipoprotein variables in northern France
18. Lack of association between genetic variations of apo A-1, C-III, A-IV gene cluster and myocardial infarction in a sample of European males: ECTIM study
19. Variation at the lipoprotein lipase and apolipoprotein AI-CIII gene loci are associated with fasting lipid and lipoprotein traits in a population sample from Iceland: Interaction between genotype, gender, and smoking status
20. Variability gene effects of DNA polymorphisms at the apo B, apo A I/C III and apo E loci on serum lipids: The Cardiovascular Risk in Young Finns Study
21. Patterns of association between genetic variability in apolipoprotein (apo) B, apo AI-CIII-AIV, and cholesterol ester transfer protein gene regions and quantitative variation in lipid and lipoprotein traits: Influence of gender and exogenous hormones
22. Role of genetic variation at the apo AI-CIII-AIV gene cluster in determining plasma apo AI levels in boys and girls
23. Restriction fragment length polymorphisms associated with abnormal lipid levels in an adolescent population
24. Cladistic analysis of the apolipoprotein AI-CIII-AIV gene cluster using a healthy French Canadian sample. I. Haploid analysis
25. Fat ingestion is associated with increased levels of apoC-III- and apoE- B-containing lipoprotein particles in humans
26. Apolipoprotein composition as the basis for classifying plasma lipoproteins. Characterization of ApoA- and ApoB-containing lipoprotein families
27. Quantitative determination of different apolipoprotein B containing lipoproteins by an enzyme linked immunosorbent assay: Apo B with apo C-III and apo B with apo E
28. Modulation of lipoprotein B binding to the LDL receptor by exogenous lipids and apolipoproteins CI, CII, CIII, and E
29. Interaction of LpB, LpB:E, LpB:C-III, and LpB:C-III:E lipoproteins with the low density lipoprotein receptor of HeLa cells
30. Lipoprotein composition changes induced by fenofibrate in dysbetalipoproteinemia type III
31. Profiles of apolipoproteins and apolipoprotein B-containing lipoprotein particles in dyslipoproteinemias
32. Common genomic variants associated with variation in plasma lipoproteins in young aboriginal Canadians
33. Common genomic variation in the APOC3 promoter associated with variation in plasma lipoproteins
34. Polymorphic markers in apolipoprotein C-III gene flanking regions and hypertriglyceridemia
35. Hypertriglyceridemia and the apolipoprotein CIII gene locus: Lack of association with the variant insulin response element in Italian school children